Scott Requadt
CIK 1664852 · Chief Executive Officer · last filed 2025-10-15
Scott Requadt is a Chief Executive Officer who has filed 19 SEC Form 4 insider transactions across 4 companies since 2017. Across all open-market trades the lifetime net is +$239.4K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
19
$239.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ESSA Pharma Inc. (EPIX) Delisted | Director | 42,502 | $0.20 | $8.6K | $0 | 5 | 2024-03-28 |
| Tourmaline Bio, Inc. (TALS) Delisted | Chief Executive Officer | 1,028,169 | $27.20 | $27.97M | $239.4K | 7 | 2023-07-06 |
| VBI Vaccines Inc/BC (VBIV) Delisted | Director | 37,500 | $0.07 | $2.4K | $0 | 5 | 2019-02-04 |
| Tectonic Therapeutic, Inc. (AVRO) Delisted | Director | 2,962,325 | $16.80 | $49.77M | $0 | 1 | 2018-06-25 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-15 | — | Disp (D) | −30,002 | $0 | |
| 2024-03-28 | ESSA Pharma Inc. (EPIX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-16 | ESSA Pharma Inc. (EPIX) Delisted | Other (J) | −30,002 | $0 | EDGAR |
| 2023-07-06 | Tourmaline Bio, Inc. (TALS) Delisted | Tax (F) | −11,786 | -$36.3K | EDGAR |
| 2023-02-03 | Tourmaline Bio, Inc. (TALS) Delisted | Grant (A) | +4 | $3 | EDGAR |
| 2022-11-01 | ESSA Pharma Inc. (EPIX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-09-13 | Tourmaline Bio, Inc. (TALS) Delisted | Grant (A) | +80,000 | $0 | EDGAR |
| 2022-08-02 | Tourmaline Bio, Inc. (TALS) Delisted | Buy (P) | +39,382 | $167.4K | EDGAR |
| 2022-07-28 | Tourmaline Bio, Inc. (TALS) Delisted | Buy (P) | +8,618 | $36.6K | EDGAR |
| 2022-07-26 | Tourmaline Bio, Inc. (TALS) Delisted | Buy (P) | +9,444 | $35.4K | EDGAR |